AP-1 Factors Play an Important Role in Transformation Induced by the v-rel Oncogene

REFERENCES

• Angel, P., I. Baumann, B. Stein, H. Delius, H. J. Rahmsdorf, and P. Herrlich 1987. 12-O-tetradecanoyl-phorbol-13-acetate induction of the human collagenase gene is mediated by an inducible enhancer element located in the 5′-flanking region. Mol. Cell. Biol. 7: 2256–2266.
   PubMed Web of Science ®Google Scholar
• Angel, P., K. Hattori, T. Smeal, and M. Karin 1988. The jun proto-oncogene is positively autoregulated by its product, Jun/AP-1. Cell 55: 875–885.
   PubMed Web of Science ®Google Scholar
• Angel, P., M. Imagawa, R. Chiu, B. Stein, R. J. Imbra, H. J. Rahmsdorf, C. Jonat, P. Herrlich, and M. Karin 1987. Phorbol ester-inducible genes contain a common cis element recognized by a TPA-modulated trans-acting factor. Cell 49: 729–739.
   PubMed Web of Science ®Google Scholar
• Angel, P., and M. Karin 1991. The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation. Biochim. Biophys. Acta 1072: 129–157.
   PubMed Web of Science ®Google Scholar
• Ballard, D. W., W. H. Walker, S. Doerre, P. Sista, J. A. Molitor, E. P. Dixon, N. J. Peffer, M. Hannink, and W. C. Greene 1990. The v-rel oncogene encodes a κB enhancer binding protein that inhibits NF-κB function. Cell 63: 803–814.
   PubMed Web of Science ®Google Scholar
• Beg, A. A., Baldwin, A. S.Jr. 1993. The IκB proteins: multifunctional regulators of Rel/NF-κB transcription factors. Genes Dev. 7: 2064–2070.
   PubMed Web of Science ®Google Scholar
• Beug, H., H. Müller, S. Grieser, G. Doederlein, and T. Graf 1981. Hematopoietic cells transformed in vitro by REV-T avian reticuloendotheliosis virus express characteristics of very immature lymphoid cells. Virology 115: 295–309.
   PubMed Web of Science ®Google Scholar
• Blank, V., P. Kourilsky, and A. Israel. 1992. NF-κB and related proteins: Rel/dorsal homologies meet ankyrin-like repeats. Trends Biochem. Sci. 17: 135–140.
   PubMed Web of Science ®Google Scholar
• Boehmelt, G., J. Madruga, P. Dörfler, K. Briegel, H. Schwartz, P. J. Enrietto, and M. Zenke 1995. Dendritic cell progenitor is transformed by a conditional v-Rel estrogen receptor fusion protein v-RelER. Cell 80: 341–352.
   PubMed Web of Science ®Google Scholar
• Boehmelt, G., A. Walker, N. Kabrun, G. Mellitzer, H. Beug, M. Zenke, and P. J. Enrietto 1992. Hormone-regulated v-rel estrogen receptor fusion protein: reversible induction of cell transformation and cellular gene expression. EMBO J. 11: 4641–4652.
   PubMedGoogle Scholar
• Bose, H. R.Jr. 1992. The Rel family: models for transcriptional regulation and oncogenic transformation. Biochim. Biophys. Acta 114: 1–17.
   Google Scholar
• Brown, P. H., R. Alani, L. H. Preis, E. Szabo, and M. J. Birrer 1993. Suppression of oncogene-induced transformation by a deletion mutant of c-jun. Oncogene 8: 877–886.
   PubMed Web of Science ®Google Scholar
• Cahill, M. A. 1997. c-Fos transrepression revisited. FEBS Lett. 400: 9–10.
   PubMedGoogle Scholar
• Castellazzi, M., J.-P. Dangy, F. Mechta, S.-I. Hirai, M. Yaniv, J. Samarut, A. Lassailly, and G. Brun 1990. Overexpression of avian or mouse c-jun in primary chick embryo fibroblasts confers a partially transformed phenotype. Oncogene 5: 1541–1547.
   PubMedGoogle Scholar
• Cavigelli, M., F. Dolfi, F.-X. Claret, and M. Karin 1995. Induction of c-fos expression through JNK-mediated TCF/Elk-1 phosphorylation. EMBO J. 14: 5957–5964.
   PubMedGoogle Scholar
• Chen, C., and H. Okayama 1987. High-efficiency transformation of mammalian cells by plasmid DNA. Mol. Cell. Biol. 7: 2745–2752.
   PubMed Web of Science ®Google Scholar
• Cheng, Q., C. A. Cant, T. Moll, R. Hofer-Warbinek, E. Wagner, M. L. Birnstiel, F. H. Bach, and R. de Martin 1994. NF-κB subunit specific regulation of the IκBα promoter. J. Biol. Chem. 269: 13551–13557.
   PubMed Web of Science ®Google Scholar
• Chiao, P. J., S. Miyamoto, and I. M. Verma 1994. Autoregulation of IκBα activity. Proc. Natl. Acad. Sci. USA 91: 28–32.
   PubMed Web of Science ®Google Scholar
• Chomczynski, P., and N. Sacchi 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162: 156–159.
   PubMed Web of Science ®Google Scholar
• Diehl, J. A., and M. Hannink 1993. Heterologous C-terminal sequences disrupt transcriptional activation and oncogenesis by p 59v-rel. J. Virol. 67: 7161–7171.
   PubMedGoogle Scholar
• Franklin, R. B., C.-Y. Kang, K. M.-M. Wan, Bose H. R., Jr. 1977. Transformation of chick embryo fibroblasts by reticuloendotheliosis virus. Virology 83: 313–321.
   PubMed Web of Science ®Google Scholar
• Fujii, M., T. Minamino, M. Nomura, K.-I. Miyamoto, J. Tanaka, and M. Seiki 1996. Selective activation of the proto-oncogene c-jun promoter by the transforming protein v-Rel. Oncogene 12: 2193–2202.
   PubMedGoogle Scholar
• Fujiwara, K. T., K. Ashida, H. Nishina, H. Iba, N. Miyajima, M. Nishizawa, and S. Kawai 1987. The chicken c-fos gene: cloning and nucleotide sequence analysis. J. Virol. 61: 4012–4018.
   PubMed Web of Science ®Google Scholar
• Ghosh, S., A. M. Gifford, L. R. Riviere, P. Tempst, G. P. Nolan, and D. Baltimore 1990. Cloning of the p50 DNA binding subunit of NF-κB: homology to rel and dorsal. Cell 62: 1019–1029.
   PubMed Web of Science ®Google Scholar
• Gille, H., M. Kortenjann, T. Strahl, and P. E. Shaw 1996. Phosphorylation-dependent formation of a quaternary complex at the c-fos SRE. Mol. Cell. Biol. 16: 1094–1102.
   PubMedGoogle Scholar
• Gilmore, T. D. 1991. Malignant transformation by mutant Rel proteins. Trends Genet. 7: 318–322.
   PubMed Web of Science ®Google Scholar
• Gilmore, T. D. 1992. Role of rel family genes in normal and malignant lymphoid cell growth. Cancer Surv. 15: 69–87.
   PubMedGoogle Scholar
• Gilmore, T. D., and P. J. Morin 1993. The IκB proteins: members of a multifunctional family. Trends Genet. 9: 427–433.
   PubMed Web of Science ®Google Scholar
• Gilmore, T. D., and H. M. Temin 1988. v-rel oncoproteins in the nucleus and in the cytoplasm transform chicken spleen cells. J. Virol. 62: 703–714.
   PubMedGoogle Scholar
• Gilmore, T. D., D. W. White, S. Sarkar, and S. Sif 1995. Malignant transformation of cells by the v-Rel oncoprotein The DNA provirus: Howard Temin’s scientific legacy. In: Cooper, G. M., R. G. Temin, and B. Sugden109–128American Society for Microbiology, Washington, D.C.
   Google Scholar
• Gutman, A., and B. Wasylyk 1991. Nuclear targets for transcription regulation by oncogenes. Trends Genet. 7: 49–54.
   PubMedGoogle Scholar
• Hanning, M., and H. M. Temin 1989. Transactivation of gene expression by nuclear and cytoplasmic rel proteins. Mol. Cell. Biol. 9: 4323–4336.
   PubMedGoogle Scholar
• Hartl, M., J. T. Hutchins, and P. K. Vogt 1991. The chicken junD gene and its product. Oncogene 6: 1623–1631.
   PubMedGoogle Scholar
• Havarstein, L. S., I. M. Morgan, W.-Y. Wong, and P. K. Vogt 1992. Mutations in the Jun Delta region suggest an inverse correlation between transformation and transcription activation. Proc. Natl. Acad. Sci. USA 89: 618–622.
   PubMedGoogle Scholar
• Henkel, T., U. Zabel, K. van Zee, J. M. Müller, E. Fanning, and P. A. Baeuerle 1992. Intramolecular masking of the nuclear location signal and dimerization domain of the precursor for the p50 NF-κB subunit. Cell 68: 1121–1133.
   PubMed Web of Science ®Google Scholar
• Hill, C. S., and R. Treisman 1995. Differential activation of c-fos promoter elements by serum, lysophosphatidic acid, G proteins and polypeptide growth factors. EMBO J. 14: 5037–5047.
   PubMed Web of Science ®Google Scholar
• Hrdlickova, R., J. Nehyba, and E. H. Humphries 1994. v-rel induces expression of three avian immunoregulatory surface receptors more efficiently than c-rel. J. Virol. 68: 308–319.
   PubMedGoogle Scholar
• Hrdlickova, R., J. Nehyba, A. Roy, E. H. Humphries, Bose H. R., Jr. 1995. The relocalization of v-Rel from the nucleus to the cytoplasm coincides with induction of expression of Ikba and nfkb1 and stabilization of IκB-α. J. Virol. 69: 403–413.
   PubMedGoogle Scholar
• Hunter, T., and M. Karin 1992. The regulation of transcription by phosphorylation. Cell 70: 375–387.
   PubMed Web of Science ®Google Scholar
• Inoue, J.-I., L. D. Kerr, L. J. Ransone, E. Bengal, T. Hunter, and I. M. Verma 1991. c-rel activates but v-rel suppresses transcription from κB sites. Proc. Natl. Acad. Sci. USA 88: 3715–3719.
   PubMedGoogle Scholar
• Ito, C. Y., A. G. Kazantsev, Baldwin A. S., Jr. 1994. Three NF-κB sites in the IκBα promoter are required for induction of gene expression by TNFα. Nucleic Acids Res. 22: 3787–3792.
   PubMedGoogle Scholar
• Kabrun, N., J. W. Hodgson, M. Doemer, G. Mak, Franza B. R., Jr., and P. J. Enrietto 1991. Interaction of the v-rel protein with an NF-κB DNA binding site. Proc. Natl. Acad. Sci. USA 88: 1783–1787.
   PubMedGoogle Scholar
• Karin, M. 1995. The regulation of AP-1 activity by mitogen-activated protein kinases. J. Biol. Chem. 270: 16483–16486.
   PubMed Web of Science ®Google Scholar
• Kerr, L. D., J.-I. Inoue, N. Davis, E. Link, P. A. Baeuerle, Bose H. R., Jr., and I. M. Verma 1991. The Rel-associated pp40 protein prevents DNA binding of Rel and NF-κB: relationship with IκBβ and regulation by phosphorylation. Genes Dev. 5: 1464–1476.
   PubMedGoogle Scholar
• Kieran, M., V. Blank, F. Logeat, J. Vanderkerckhove, F. Lottspeich, O. Le Bail, M. B. Urban, P. Kourilsky, P. A. Baeuerle, and A. Israel 1990. The DNA binding subunit of NF-κB is identical to factor KBF1 and homologous to the rel oncogene product. Cell 62: 1007–1018.
   PubMed Web of Science ®Google Scholar
• König, H., H. Ponta, U. Rahmsdorf, M. Büscher, A. Schönthal, H. J. Rahmsdorf, and P. Herrlich 1989. Autoregulation of fos: the dyad symmetry element as the major target of repression. EMBO J. 8: 2559–2566.
   PubMedGoogle Scholar
• Kovary, K., and R. Bravo 1991. Expression of different Jun and Fos proteins during the G0-to-G1 transition in mouse fibroblasts: in vitro and in vivo associations. Mol. Cell. Biol. 11: 2451–2459.
   PubMedGoogle Scholar
• Kralova, J., J. D. Schatzle, W. Bargmann, Bose H. R., Jr. 1994. Transformation of avian fibroblast overexpression of c-rel proto-oncogene and a variant of c-rel lacking 40 C-terminal amino acids. J. Virol. 68: 2073–2083.
   PubMed Web of Science ®Google Scholar
• Kralova, J., J. D. Schatzle, A. S. Liss, W. Bargmann, Bose H. R., Jr. 1996. Synergistic stimulation of avian IκBα transcription by rel and fos/jun factors. Oncogene 12: 2595–2604.
   PubMedGoogle Scholar
• Kumar, S., A. B. Rabson, and C. Gélinas 1992. The RxxRxRxxC motif conserved in all Rel/κB proteins is essential for the DNA binding activity and redox regulation of the v-Rel oncoprotein. Mol. Cell. Biol. 12: 3094–3106.
   PubMed Web of Science ®Google Scholar
• Le Bail, O., R. Schmidt-Ullrich, and A. Israel 1993. Promoter analysis of the gene encoding the IκBα/ MAD-3 inhibitor of NF-κB: positive regulation by members of the rel/NF-κB family. EMBO J. 12: 5043–5049.
   PubMed Web of Science ®Google Scholar
• Lewis, R. B., J. McClure, B. Rup, D. W. Niesel, R. F. Garry, J. D. Hoelzer, K. Nazerian, Bose H. R., Jr. 1981. Avian reticuloendotheliosis virus: identification of the hematopoietic target cell for transformation. Cell 25: 421–431.
   PubMed Web of Science ®Google Scholar
• Lim, M. Y., N. Davis, J. Zhang, Bose H. R., Jr. 1990. The v-rel oncogene product is complexed with the cellular proteins including its proto-oncogene product and heat shock protein 70. Virology 175: 149–160.
   PubMedGoogle Scholar
• McDonnel, P. C., S. Kumar, A. B. Rabson, and C. Gélinas 1992. Transcriptional activity of rel family proteins. Oncogene 7: 163–170.
   PubMedGoogle Scholar
• Miller, A., T. Curran, and I. M. Verma 1984. c-fos protein can induce cellular transformation: a novel mechanism of activation of a cellular oncogene. Cell 36: 51–60.
   PubMed Web of Science ®Google Scholar
• Moore, B. E., Bose, H. R.Jr. 1988. Expression of the v-rel oncogene in reticuloendotheliosis virus-transformed fibroblasts. Virology 162: 377–387.
   PubMedGoogle Scholar
• Morrison, L. E., G. Boehmelt, H. Beug, and P. J. Enrietto 1991. Expression of v-rel in a replication competent virus: transformation and biochemical characterization. Oncogene 6: 1657–1666.
   PubMedGoogle Scholar
• Morrison, L. E., G. Boehmelt, and P. J. Enrietto 1992. Mutations in the rel-homology domain alter the biochemical properties of v-rel and render it transformation defective in chicken embryo fibroblasts. Oncogene 7: 1137–1147.
   PubMedGoogle Scholar
• Nishimura, T., and P. K. Vogt 1988. The avian cellular homolog of the oncogene jun. Oncogene 3: 659–663.
   PubMedGoogle Scholar
• Nishina, H., H. Sato, T. Suzuki, M. Sato, and H. Iba 1990. Isolation and characterization of fra-2, an additional member of the fos gene family. Proc. Natl. Acad. Sci. USA 87: 3619–3623.
   PubMedGoogle Scholar
• Okuno, H., T. Suzuki, T. Yoshida, Y. Hashimoto, T. Curran, and H. Iba 1991. Inhibition of jun transformation by a mutated fos gene: design of an anti-oncogene. Oncogene 6: 1491–1497.
   PubMedGoogle Scholar
• Richardson, P. M., and T. G. Gilmore 1991. v-Rel is an inactive member of the Rel family of transcriptional activating proteins. J. Virol. 65: 3122–3130.
   PubMed Web of Science ®Google Scholar
• Sambrook, J., F. F. Fritsch, and T. Maniatis 1989. Molecular cloning: a laboratory manual2nd ed. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
   Google Scholar
• Sarkar, S., and T. D. Gilmore 1993. Transformation by the v-Rel oncoprotein requires sequences carboxy-terminal to the Rel homology domain. Oncogene 8: 2245–2252.
   PubMedGoogle Scholar
• Schatzle, J. D., J. Kralova, Bose H. R., Jr. 1995. Avian IκBα is transcriptionally induced by c-Rel and v-Rel with different kinetics. J. Virol. 69: 5383–5390.
   PubMedGoogle Scholar
• Schreiber, S., P. Matthias, M. M. Müller, and W. Schaffner 1989. Rapid detection of octamer binding proteins with ‘mini-extracts’ prepared from a small number of cells. Nucleic Acids Res. 17: 6419.
   PubMed Web of Science ®Google Scholar
• Shaw, P. E., S. Frasch, and A. Nordheim 1989. Repression of c-fos transcription is mediated through p 67SRF bound to the SRE. EMBO J. 8: 2567–2574.
   PubMedGoogle Scholar
• Sif, S., A. J. Capobianco, and T. D. Gilmore 1993. The v-Rel oncoprotein increases expression from Sp1 site-containing promoters in chicken embryo fibroblasts. Oncogene 8: 2501–2509.
   PubMedGoogle Scholar
• Stephens, R. M., N. R. Rice, R. R. Hiebsch, Bose H. R., Jr., and R. V. Gilden 1983. Nucleotide sequence of v-rel: the oncogene of reticuloendotheliosis virus. Proc. Natl. Acad. Sci. USA 80: 6229–6233.
   PubMedGoogle Scholar
• Suzuki, T., M. Murakami, N. Onai, E. Fukuda, Y. Hashimoto, M. H. Sonobe, T. Kameda, M. Ichinose, K. Miki, and H. Iba 1994. Analysis of AP-1 function in cellular transformation pathways. J. Virol. 68: 3527–3535.
   PubMed Web of Science ®Google Scholar
• Suzuki, T., H. Okuno, T. Yoshida, T. Endo, H. Nishina, and H. Iba 1991. Difference in transcriptional regulatory function between c-Fos and Fra-2. Nucleic Acids Res. 19: 5537–5542.
   PubMedGoogle Scholar
• Traechner, E.B.-M., S. Wilk, and P. A. Baeuerle 1994. A proteasome inhibitor prevents activation of NF-κB and stabilizes a newly phosphorylation form of IκBα that is still bound to NF-κB. EMBO J. 13: 5433–5441.
   PubMedGoogle Scholar
• Treisman, R. 1992. The serum response element. Trends Biochem. Sci. 17: 423–426.
   PubMed Web of Science ®Google Scholar
• Treisman, R. 1994. Ternary complex factors: growth factor regulated transcriptional activators. Curr. Opin. Genet. Dev. 4: 96–101.
   PubMedGoogle Scholar
• Tsurumi, C., N. Ishida, T. Tamura, A. Kakizuka, E. Nishida, E. Okumura, T. Kishimoto, M. Inakagi, K. Okazaki, N. Sagata, A. Ichihara, and K. Tanaka 1995. Degradation of c-Fos by the 26S proteasome is accelerated by c-Jun and multiple protein kinases. Mol. Cell. Biol. 15: 5682–5687.
   PubMedGoogle Scholar
• Walker, A. K., and P. J. Enrietto 1996. Analysis of the role of v-rel in transcriptional regulation of high mobility group protein 14. Oncogene 12: 2515–2525.
   PubMedGoogle Scholar
• Walker, W. H., B. Stein, P. A. Ganchi, J. A. Hoffman, P. A. Kaufman, D. W. Ballard, M. Hannink, and W. C. Greene 1992. The v-rel oncogene: insights into the mechanism of transcriptional activation, repression, and transformation. J. Virol. 66: 5018–5029.
   PubMedGoogle Scholar
• Wilhelmsen, K. C., K. Eggleton, and H. M. Temin 1984. Nucleic acid sequence of the oncogene v-rel in reticuloendotheliosis virus strain T and its cellular homolog, the proto-oncogene c-rel. J. Virol. 52: 172–182.
   PubMed Web of Science ®Google Scholar
• Wilson, T., and R. Treisman 1988. Fos C-terminal mutations block down-regulation of c-fos transcription following serum stimulation. EMBO J. 7: 4193–4201.
   PubMedGoogle Scholar
• Zhang, J., W. Olson, D. Ewert, W. Bargmann, Bose H. R., Jr. 1991. The v-rel oncogene of avian reticuloendotheliosis virus transforms immature and mature lymphoid cells in B cell lineage in vitro. Virology 183: 457–466.
   PubMed Web of Science ®Google Scholar
• Zhang, J., Bose, H. R.Jr. 1989. Acquisition of new proviral copies in avian lymphoid cells transformed by reticuloendotheliosis virus. J. Virol. 63: 1107–1115.
   PubMedGoogle Scholar
• Zinck, R., R. A. Hipskind, V. Pingoud, and A. Nordheim 1993. c-fos transcriptional activation and repression correlate temporally with the phosphorylation status of TCF. EMBO J. 12: 2377–2387.
   PubMed Web of Science ®Google Scholar